Transcatheter procedures are transforming the treatment of heart valve conditions, particularly with regards to aortic valve stenosis. As TAVR is still a fairly new technology, challenges remain where precise pre-operative planning can play a crucial role. FEops is a company that focuses on the role simulations can play in optimizing transcatheter cardiovascular devices and patient-tailored interventions. They rely on the Mimics Innovation Suite to prepare the models which are used in these simulations.
Why choose Mimics® Innovation Suite?
- It's the industry standard for accurate segmentation
- Importing a wide variety of medical imaging formats is simple
- It's easy to use and helps to reduce training time
- Mimics® has the regulatory clearance to be considered a medical device